TrialThe lancet. HIV2022

Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.

Ethan Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.